BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32187044)

  • 21. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
    Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion].
    Li HL; Mo CH; Xie L; Wu YX; Zeng M; Mao RJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):58-63. PubMed ID: 38178748
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall.
    Kerr DA; Thompson LDR; Tafe LJ; Jo VY; Neyaz A; Divakar P; Paydarfar JA; Pastel DA; Shirai K; John I; Seethala RR; Salgado CM; Deshpande V; Bridge JA; Kashofer K; Brčić I; Linos K
    Am J Surg Pathol; 2021 Dec; 45(12):1707-1719. PubMed ID: 34001695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens.
    Montoya-Cerrillo DM; Diaz-Perez JA; Velez-Torres JM; Montgomery EA; Rosenberg AE
    Genes Chromosomes Cancer; 2021 Oct; 60(10):687-694. PubMed ID: 34184341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
    Folpe AL; McKenney JK; Bridge JA; Weiss SW
    Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis.
    Li Y; Li D; Wang J; Tang J
    Diagn Pathol; 2023 Mar; 18(1):41. PubMed ID: 36998041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current landscape of rhabdomyosarcomas: an update.
    Leiner J; Le Loarer F
    Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma.
    Liu J; Guzman MA; Pezanowski D; Patel D; Hauptman J; Keisling M; Hou SJ; Papenhausen PR; Pascasio JM; Punnett HH; Halligan GE; de Chadarévian JP
    Mod Pathol; 2011 Oct; 24(10):1327-35. PubMed ID: 21666686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyosarcoma With
    Ishiyama T; Kato I; Ito J; Matsumura M; Saito K; Kawabata Y; Kato S; Takeyama M; Fujii S
    Int J Surg Pathol; 2023 Aug; 31(5):805-812. PubMed ID: 36437645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma.
    Fu L; Jin Y; Jia C; Zhang J; Tai J; Li H; Chen F; Shi J; Guo Y; Ni X; He L
    Sci China Life Sci; 2017 Jul; 60(7):721-728. PubMed ID: 28646473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
    Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
    J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
    Rekhi B; Singhvi T
    APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma-diagnostic challenge and report of two cases.
    Carrillo-Ng H; Liang Y; Chang S; Afkhami M; Gernon T; Bell D; Arias-Stella JA
    Genes Chromosomes Cancer; 2023 Jul; 62(7):430-436. PubMed ID: 37057803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving classification of rhabdomyosarcoma.
    Agaram NP
    Histopathology; 2022 Jan; 80(1):98-108. PubMed ID: 34958505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhabdomyosarcoma With Epithelioid Features And
    Rakheja D; Park JY; Yang MS; Martinez DP; Koduru P; Wilson KS; Garcia R; Uddin N
    Int J Surg Pathol; 2023 Apr; 31(2):213-220. PubMed ID: 35502835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
    Yun K
    Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.
    Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R
    Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.